Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...

GenScript, founded in 2002 in New Jersey, has announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's ...

Many RNA programs are under increasing pressure to compress development timelines while ensuring consistent RNA quality and ...

GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...

GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...

March 3 (Reuters) - Moderna (MRNA.O), opens new tab has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences (ROIV.O), opens new tab, and Arbutus Biopharma (ABUS.O), opens new tab up to ...